CVS’s new drug payment plan won’t lower patients’ prices, experts warn

5 December 2023 - CVS Health is promising to simplify how its pharmacies get paid for drugs. But that doesn’t ...

Read more →

‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices

7 December 2023 - In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, ...

Read more →

Government sends mixed message to global life science investors

5 December 2023 - The Government has published new terms for the Statutory Scheme for branded medicines, maintaining sales rebates ...

Read more →

CVS plans to overhaul how much drugs cost

5 December 2023 - The nation’s biggest drugstore chain to get paid based on the amount it pays for drugs, plus ...

Read more →

Prescriptive changes for price reduction of older medicines

4 December 2023 - Changes to the Dental and Pharmaceutical Benefits Agency's regulations and general advice on the pricing of ...

Read more →

China’s new cancer drug toripalimab is approved in the US but will cost 30 times more

29 November 2023 - In China, a single dose vial costs US$280 but in the US it will have a wholesale ...

Read more →

Novartis urges Court to hand it quick win in drug price battle

25 November 2023 - Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said ...

Read more →

Cost of exempting sole orphan drugs from Medicare negotiation

27 November 2023 - This cross-sectional study identified 25 “sole orphan” drugs qualifying for exemption from Medicare price negotiation.  ...

Read more →

Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment

20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more ...

Read more →

Cost plus drugs: an altruistic capitalist venture

15 November 2023 - In a country built on capitalist ideology, it’s no secret that the United States health care industry ...

Read more →

In shocking reversal, CMS wants to allow Medicare Part D plan sponsors to substitute non-interchangeable biosimilars

10 November 2023 - On November 6, 2023, CMS announced a proposed Rule that would permit Medicare Part D plan sponsors ...

Read more →

Same drug, two prices: why the higher price prevails

8 November 2023 - Patients are paying hundreds of dollars more for a prescription than they would if their health plan ...

Read more →

HHS considers removing J&J’s Stelara from Medicare drug price negotiations

7 November 2023 - The Department of Health and Human Services in a supplemental court filing posted late last week ...

Read more →

Biogen-Sage Therapeutics post partum depression pill priced at $15,900

7 November 2023 - Sage Therapeutics has priced the oral post partum depression pill it developed with partner Biogen at ...

Read more →

Key Senate panel to consider PBM, drug pricing reform package

2 November 2023 - A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure ...

Read more →